Huaifeng Li

No. 1665 Kongjiang Road
Shanghai, 200092, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

TRIM21-mediated ubiquitylation of TAT suppresses liver metastasis in gallbladder cancer.

TRIM21-mediated ubiquitylation of TAT suppresses liver metastasis in gallbladder cancer.

Journal: Cancer letters

Published: March 10, 2024

Multimodal integration of liquid biopsy and radiology for the noninvasive diagnosis of gallbladder cancer and benign disorders.

Multimodal integration of liquid biopsy and radiology for the noninvasive diagnosis of gallbladder cancer and benign disorders.

Journal: Cancer cell

Published: November 09, 2023

Acylcarnitines promote gallbladder cancer metastasis through lncBCL2L11-THOC5-JNK axis.

Acylcarnitines promote gallbladder cancer metastasis through lncBCL2L11-THOC5-JNK axis.

Journal: Journal of translational medicine

Published: October 03, 2023

Hepatopancreatoduodenectomy for advanced biliary malignancies.

Hepatopancreatoduodenectomy for advanced biliary malignancies.

Journal: Chinese medical journal

Published: August 02, 2022

LncRNA MNX1-AS1 sustains inactivation of Hippo pathway through a positive feedback loop with USP16/IGF2BP3 axis in gallbladder cancer.

LncRNA MNX1-AS1 sustains inactivation of Hippo pathway through a positive feedback loop with USP16/IGF2BP3 axis in gallbladder cancer.

Journal: Cancer letters

Published: June 21, 2022

Correction to: Dihydroartemisinin inhibits TCTPdependent metastasis in gallbladder cancer.

Correction to: Dihydroartemisinin inhibits TCTPdependent metastasis in gallbladder cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: April 04, 2022

Correction: EIF3D promotes gallbladder cancer development by stabilizing GRK2 kinase and activating PI3K-AKT signaling pathway.

Correction: EIF3D promotes gallbladder cancer development by stabilizing GRK2 kinase and activating PI3K-AKT signaling pathway.

Journal: Cell death & disease

Published: December 21, 2021

Modified FOLFIRINOX versus gemcitabine plus oxaliplatin as first-line chemotherapy for patients with locally advanced or metastatic cholangiocarcinoma: a retrospective comparative study.

Modified FOLFIRINOX versus gemcitabine plus oxaliplatin as first-line chemotherapy for patients with locally advanced or metastatic cholangiocarcinoma: a retrospective comparative study.

Journal: BMC cancer

Published: December 11, 2020

Long noncoding RNA lncGALM increases risk of liver metastasis in gallbladder cancer through facilitating N-cadherin and IL-1β-dependent liver arrest and tumor extravasation.

Long noncoding RNA lncGALM increases risk of liver metastasis in gallbladder cancer through facilitating N-cadherin and IL-1β-dependent liver arrest and tumor extravasation.

Journal: Clinical and translational medicine

Published: May 31, 2020

A metagenomic study of biliary microbiome change along the cholecystitis-carcinoma sequence.

A metagenomic study of biliary microbiome change along the cholecystitis-carcinoma sequence.

Journal: Clinical and translational medicine

Published: April 19, 2020

Correction to: Dihydroartemisinin inhibits TCTP-dependent metastasis in gallbladder cancer.

Correction to: Dihydroartemisinin inhibits TCTP-dependent metastasis in gallbladder cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: September 05, 2019

NOP2/Sun RNA methyltransferase 2 promotes tumor progression via its interacting partner RPL6 in gallbladder carcinoma.

NOP2/Sun RNA methyltransferase 2 promotes tumor progression via its interacting partner RPL6 in gallbladder carcinoma.

Journal: Cancer science

Published: May 13, 2019

Showing 1-12 of 24

Last Updated: 09/26/2026